ZOM Stock Earnings: Zomedica Misses Revenue for Q2 2024
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 14 2024
0mins
Should l Buy ?
Source: Business Insider
Zomedica Q2 2024 Earnings Report: Zomedica reported a second quarter earnings per share of -1 cent and revenue of $6.13 million, which fell short of analyst expectations of $6.26 million by 2.06%.
InvestorPlace Earnings Automation: InvestorPlace Earnings utilizes TradeSmith data to automate the coverage of quarterly earnings reports, providing timely updates on key financial metrics without human intervention.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
